CXCL8 and skin squamous cell carcinoma: A study collected and analyzed transcriptomic data from patients with cSCC treated with cemiplimab and found that the CCL-20 and CXCL-8 (IL8) genes were significantly upregulated in patients resistant to PD-1 therapy.